Sarepta Therapeutics (SRPT) Debt Ratio (2010 - 2026)

Sarepta Therapeutics' Debt Ratio history runs 17 years deep, the most recent figure standing at 0.26 for Q1 2026.

• In Q1 2026, Debt Ratio fell 19.73% year-over-year to 0.26; the TTM figure through Mar 2026 stood at 0.26 (down 19.73% YoY), while the FY2025 annual figure was 0.25, down 13.75% from the prior year.
• Debt Ratio was 0.26 for Q1 2026 at Sarepta Therapeutics, up from 0.25 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.49 in Q4 2022 to a low of 0.25 in Q4 2025.
• Historically, Debt Ratio has averaged 0.36 across 5 years, with a median of 0.36 in 2022.
• The sharpest annual moves came in 2022 and 2024: Debt Ratio jumped 41.67% in 2022, then decreased 24.34% in 2024.
• A 5-year view of Debt Ratio shows it stood at 0.49 in 2022, then dropped by 23.18% to 0.38 in 2023, then slipped by 24.34% to 0.29 in 2024, then dropped by 13.75% to 0.25 in 2025, then climbed by 6.54% to 0.26 in 2026.
• The last three Debt Ratio figures came in at 0.26 (Q1 2026), 0.25 (Q4 2025), and 0.31 (Q3 2025), per Business Quant data.